These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1317920)

  • 21. Comparison of D-securinine and L-securinine metabolism in mice and rats.
    Zhang JT; Qu ZW
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(2):105-8. PubMed ID: 3432234
    [No Abstract]   [Full Text] [Related]  

  • 22. [Total synthesis of securinine].
    Xi FD; Liang XT
    Yao Xue Xue Bao; 1992; 27(5):349-52. PubMed ID: 1442055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. gamma-Aminobutyric acid receptor binding antagonism by the amidine steroid RU5135.
    Olsen RW
    Eur J Pharmacol; 1984 Aug; 103(3-4):333-7. PubMed ID: 6092106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological comparison between virosecurinine and securinine].
    Pu H; Zhao J; Pong B; Xu S
    Zhong Yao Cai; 2001 Apr; 24(4):278-80. PubMed ID: 12587161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of GABAA receptor ligands on noradrenaline concentration and beta-adrenoceptor binding in mouse cerebral cortex.
    Gettins D; Goldsack N; Ibegbuna V; Stanford SC
    Psychopharmacology (Berl); 1990; 102(3):357-63. PubMed ID: 1701263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic and systems biology analysis of monocytes exposed to securinine, a GABA(A) receptor antagonist and immune adjuvant.
    Shipman M; Lubick K; Fouchard D; Guram R; Grieco P; Jutila M; Dratz EA
    PLoS One; 2012; 7(9):e41278. PubMed ID: 23028424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiovascular effects of lateral intracerebroventricular injection of L-securinine].
    Zhao XY; Jiang ZY; Peng JZ
    Sheng Li Xue Bao; 2000 Dec; 52(6):473-8. PubMed ID: 11941410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABAA antagonists reveal binding sites for [35S]TBPS in cerebellar granular cell layer.
    Korpi ER; Lüddens H; Seeburg PH
    Eur J Pharmacol; 1992 Feb; 211(3):427-8. PubMed ID: 1319916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
    Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
    J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First diastereoselective chiral synthesis of (-)-securinine.
    Honda T; Namiki H; Kaneda K; Mizutani H
    Org Lett; 2004 Jan; 6(1):87-9. PubMed ID: 14703357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The formal total synthesis of securinine].
    Niu CS; Liang XT
    Yao Xue Xue Bao; 1988 May; 23(5):347-50. PubMed ID: 2905568
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect and mechanism of securinine on synaptic transmission in the dentate gyrus of anesthetized rats].
    Xu L; Zhang JT
    Yao Xue Xue Bao; 2001 Aug; 36(8):565-8. PubMed ID: 12579930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural determinants for antagonist pharmacology that distinguish the rho1 GABAC receptor from GABAA receptors.
    Zhang J; Xue F; Chang Y
    Mol Pharmacol; 2008 Oct; 74(4):941-51. PubMed ID: 18599601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OPTICAL ROTATORY DISPERSION AND CIRCULAR DICHROISM OF SECURININE AND ALLOSECURININE.
    HORII ZI; IKEDA M; TAMURA Y; SAITO S; SUZUKI M; KODERA K
    Chem Pharm Bull (Tokyo); 1964 Sep; 12():1118-21. PubMed ID: 14245278
    [No Abstract]   [Full Text] [Related]  

  • 35. The sensitivity of gamma-aminobutyric acid antagonists to thiocyanate is related to the absence of a functional anionic group in their structure.
    Wermuth CG; Chambon JP; Heaulme M; Melikian A; Schlewer G; Leyris R; Biziére K
    Eur J Pharmacol; 1987 Dec; 144(3):375-8. PubMed ID: 2831069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying agonistic and antagonistic mechanisms operative at the GABA receptor.
    Galvez-Ruano E; Aprison MH; Robertson DH; Lipkowitz KB
    J Neurosci Res; 1995 Dec; 42(5):666-73. PubMed ID: 8600299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Securinega alkaloids.
    Chirkin E; Atkatlian W; Porée FH
    Alkaloids Chem Biol; 2015; 74():1-120. PubMed ID: 25845059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABAA receptor blockers reverse the inhibitory effect of GABA on brain-specific [35S]TBPS binding.
    Squires RF; Saederup E
    Brain Res; 1987 Jun; 414(2):357-64. PubMed ID: 3040167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselective approach to Securinega alkaloids. Total synthesis of securinine and (-)-norsecurinine.
    González-Gálvez D; García-García E; Alibés R; Bayón P; de March P; Figueredo M; Font J
    J Org Chem; 2009 Aug; 74(16):6199-211. PubMed ID: 19627163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system.
    Olsen RW; McCabe RT; Wamsley JK
    J Chem Neuroanat; 1990; 3(1):59-76. PubMed ID: 2156526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.